News

Acarix is a Scandinavia headquartered MedTech company marketing the CADScor®System – the innovative, non-invasive and ultra-sensitive analytical device designed to support a reliable and cost-effective rule-out of significant coronary artery disease (CAD) at the very first stage of the diagnostic pathway.

We are committed to bringing about a change in the early detection and assessment of coronary artery disease. Our latest news can be found below.

2022 03 03

CADScor®System recognized as Most Innovative Coronary Artery Disease Analytical Device 2021.

CADScor®System recognized as Most Innovative Coronary Artery Disease Analytical Device 2021.   Acarix and CADScor®System has won the Global Health & Pharma technology awards 2021 as Most Innovative Coronary Artery Disease Analytical Device 2021. We are ...

2021 07 06

Acarix presents at Life Science Investor Conference in Copenhagen

Acarix presents at Life Science Investor Conference in Copenhagen

2020 07 17

Per Persson, CEO of Acarix has been selected as an Innovation Leader at the LSI 2021 Emerging Medtech Summit.

At LSI 2021, Mr. Persson will share the story of Acarix and provide timely updates to an audience of medtech investors, strategics, and industry insiders.

2020 06 22

Interview with Dr Remde, Cardiologist in Heidelberg and since several years back a regular user of the CADScor(R)System.

Dr Remde use the CADScor(R) as a routine test in line with other non-invasive tests for ruling out CAD with high likelihood. 

2020 05 20

Redeye Research Interview with Acarix CEO Per Persson

Per Persson, gives a general update about the company's FDA application as well as the ongoing reimbursement process in Germany and the company's commercialization strategy in Europe

2020 05 05

validate-confirms-high-sensitivity-of-the-cadscorsystem

For the first time, the usage of the CADScor® System in a high prevalence cohort is described by M. Renker et al. This prospective randomized cohort was designed as technical study to confirm predicted sensitivity and specificity in a high prevalence patie...

2020 03 03

Acarix prepares the CADScor®System for the the US market

Per Person,  Acarix CEO presented the CADScor® System at the Emerging Medtech Summit in California, USA, last month. Acarix gained interest from several parties interested to support our journey towards presence in the US market.      Last week we had the...